Imbed Biosciences
Manufacturing · Wisconsin, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2241 Pinehurst Dr, Middleton, Wisconsin,...Phone Number
(888) 472-9898Website
www.imbedbio.comRevenue
$16.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Imbed Biosciences
Imbed Biosciences is a privately held medical device company focused on developing and commercializing advanced wound care solutions using its patented Synthetic Antimicrobial Matrix (SAM) technology. Its products are designed to protect wounds, manage pain, and support healing in chronic, acute, surgical, and burn wounds through innovative synthetic matrices that integrate antimicrobial and bioactive agents. The company is registered with the U.S. FDA and adheres to international quality standards.Explore more
Imbed Biosciences Org Chart
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imbed Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Imbed Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Imbed Biosciences
Earning: See what the market has to say on Imbed Biosciences recently announced quarterly report
Click to see if Imbed Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Imbed Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Imbed Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Imbed Biosciences launches new products
Check if Imbed Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Imbed Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Imbed Biosciences
Compare insights from companies similar to Imbed Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imbed Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imbed Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imbed Biosciences.
Imbed Biosciences financials insights
Gather financial insights about Imbed Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$683K
Grant
$1.5M
2016
Debt
$600K
2017
Private Equity
$1.6M
2019
Series A
$4M
2020
Debt
$150K
2024
Debt
$10M
Imbed Biosciences Tech Stack
A closer look at the technologies used by Imbed Biosciences
Most Recent Scoops
Open Position
Funding
Funding
Project
Research & Development, Intellectual Property, Safety, Governmental Affairs & Regulation, Medical Research, Clinical Operations, Regulations
New Hire
Executive Move
Executive Moves, New Hire
Imbed Biosciences News & Media
BioLab Holdings Announces Investment in Advanced Synthetic Antimicrobial -Tissue Regeneration Solutions
PHOENIX, Jan. 27, 2026 /PRNewswire/ -- BioLab Holdings, Inc., a Phoenix‑based medical manufacturer specializing in advanced wound protection technologies, has announced a strategic investment in Imbed Biosciences, Inc., the Wisconsin‑based medical device innovator behind the...Imbed Biosciences Launches Dual-Action Wound Matrix Integrating Bioburden Management and Pain Relief in a Single Solution
MIDDLETON, Wis., Aug. 28, 2025 /PRNewswire/ -- Imbed Biosciences Inc., a leader in advanced wound care technology, today announced the launch of SAM™ PainGuard™ with Lidocaine, a groundbreaking addition to its acute care portfolio of fully synthetic, antimicrobial, and biocompatible wound...Supply Chain Leadership Acknowledged for Paving the Way for MedTech Innovation and Growth
Sanjay Gupta from Imbed Biosciences Inc. Featured in The Wall Street Journal as a Distinguished Leader in Healthcare Supply Chain MIDDLETON, Wis., May 30, 2025 /PRNewswire/ -- Imbed Biosciences Inc., a leader in advanced wound care technology, is proud to announce that Sanjay Gupta, Vice...Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
MIDDLETON, Wis.--(BUSINESS WIRE)-- #Biofilm--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application to conduct a feasibility clinical trial to validate the safety of their pipeline polymeric matrix with silver and gallium ions in human donor site wounds. “The prevalence of biofilms in non-healing wounds is estimated to be 80%. With
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imbed Biosciences
Sign Up For FreeTo access detailed company insights
Imbed Biosciences is a privately held medical device company focused on developing and commercializing advanced wound care solutions using its patented Synthetic Antimicrobial Matrix (SAM) technology. Its products are designed to protect wounds, manage pain, and support healing in chronic, acute, surgical, and burn wounds through innovative synthet... Read More
